Smartphone Voice Calls Provide Early Biomarkers of Parkinsonism in Rapid Eye Movement Sleep Behavior Disorder
Type of document
článek v časopisejournal article
Peer-reviewed
publishedVersion
Author
Illner V.
Novotný M.
Kouba T.
Tykalová T.
Šimek M.
Sovka P.
Švihlík J.
Růžička E.
Šonka K.
Dušek P.
Rusz J.
Rights
Creative Commons Attribution-NoDerivs (CC BY-ND) 4.0http://creativecommons.org/licenses/by-nd/4.0/
openAccess
Metadata
Show full item recordAbstract
Background: Speech dysfunction represents one of the initial motor manifestations to develop in Parkinson's disease (PD) and is measurable through smartphone. Objective: The aim was to develop a fully automated and noise-resistant smartphone-based system that can unobtrusively screen for prodromal parkinsonian speech disorder in subjects with isolated rapid eye movement sleep behavior disorder (iRBD) in a real-world scenario. Methods: This cross-sectional study assessed regular, everyday voice call data from individuals with iRBD compared to early PD patients and healthy controls via a developed smartphone application. The participants also performed an active, regular reading of a short passage on their smartphone. Smartphone data were continuously collected for up to 3 months after the standard in-person assessments at the clinic. Results: A total of 3525 calls that led to 5990 minutes of preprocessed speech were extracted from 72 participants, comprising 21 iRBD patients, 26 PD patients, and 25 controls. With a high area under the curve of 0.85 between iRBD patients and controls, the combination of passive and active smartphone data provided a comparable or even more sensitive evaluation than laboratory examination using a high-quality microphone. The most sensitive features to induce prodromal neurodegeneration in iRBD included imprecise vowel articulation during phone calls (P = 0.03) and monopitch in reading (P = 0.05). Eighteen minutes of speech corresponding to approximately nine calls was sufficient to obtain the best sensitivity for the screening. Conclusion: We consider the developed tool widely applicable to deep longitudinal digital phenotyping data with future applications in neuroprotective trials, deep brain stimulation optimization, neuropsychiatry, speech therapy, population screening, and beyond.
Collections
- Publikační činnost ČVUT [1396]
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NoDerivs (CC BY-ND) 4.0